Nu-Med Plus, Inc.

NUMD · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$3-$21-$20-$11
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$11$9$9
Other Non-Cash-$10$30$11$0
Operating Cash Flow-$13$0$0-$2
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$13$0$0$0
Financing Cash Flow$13$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$1-$2$0-$2
Supplemental Information
Beg. Cash$1$2$2$4
End Cash$2$1$2$2
Free Cash Flow-$13$0$0-$2
Nu-Med Plus, Inc. (NUMD) Financial Statements & Key Stats | AlphaPilot